These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7349614)

  • 21. [The anti-arrhythmic activity of quinuclidine derivatives].
    Svistov AS; Skorobogatov VI
    Eksp Klin Farmakol; 1994; 57(5):20-1. PubMed ID: 7696896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac arrhythmias, anti-arrhythmic drugs and prostaglandins.
    Das UN
    J Indian Med Assoc; 1980 Jan; 74(1):23-4. PubMed ID: 7229395
    [No Abstract]   [Full Text] [Related]  

  • 23. [Relation between the serum concentration and the clinical effectiveness of anti-arrhythmia agents].
    Follath F
    Cardiology; 1983; 70 Suppl 1():108-13. PubMed ID: 6342777
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effects of propafenone in the treatment of ventricular arrhythmias with a malignant potential for resistance to conventional anti-arrhythmia medication].
    Câmpeanu A; Rădoi M; Serban-Pârâu G; Pleşca O; Nuţă M; Teodorescu V; Titirigă M
    Med Interna; 1993; 45(1-2):35-41. PubMed ID: 8081689
    [No Abstract]   [Full Text] [Related]  

  • 25. [Amiodarone in the treatment of arrhythmias].
    Raatikainen MJ; Huikuri HV
    Duodecim; 1998; 114(19):1923-36. PubMed ID: 11717746
    [No Abstract]   [Full Text] [Related]  

  • 26. Future of antiarrhythmic drugs.
    Darbar D; Roden DM
    Curr Opin Cardiol; 2006 Jul; 21(4):361-7. PubMed ID: 16755206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing oral dosing and monitoring of noncardiac toxicities with chronic amiodarone therapy.
    Tsikouris JP; White CM; Kluger J
    Conn Med; 2000 Jan; 64(1):35-8. PubMed ID: 10697362
    [No Abstract]   [Full Text] [Related]  

  • 28. Update on new antiarrhythmic drugs.
    Morton PG
    Crit Care Nurs Clin North Am; 1994 Mar; 6(1):69-83. PubMed ID: 8192885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of cholic acid-ethylene oxide compounds on ouabain-induced cardiac rhythm disorders].
    Kośmider S
    Kardiol Pol; 1972; 15(4):455-61. PubMed ID: 4641916
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anti-arrhythmia agents: results and outlook].
    Kaverina NV
    Eksp Klin Farmakol; 1994; 57(6):12-5. PubMed ID: 7756947
    [No Abstract]   [Full Text] [Related]  

  • 31. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S; Duker G; Carlsson L
    Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cardiovascular drugs. 6/12. Digitalis drugs].
    Nolin CH; Limat S; Woronoff-Lemsi MC
    Soins; 2004 Oct; (689):55-6. PubMed ID: 15586443
    [No Abstract]   [Full Text] [Related]  

  • 33. Is there a need for new antiarrhythmic drugs?
    Roden DM
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of naloxone on rhythm disorders and on the conduction system of the heart].
    Shliakhto EV; Zaĭtsev AA; Panov AV; Ardashev AV; Nifontov EM; Kashina EA; Kazarin VV; Ivanov VV
    Eksp Klin Farmakol; 1996; 59(3):34-6. PubMed ID: 8974581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Proarrhythmic effects of anti-arrhythmia agents].
    Enrico JF; Kehtari R
    Rev Med Suisse Romande; 1998 Aug; 118(8):671-90. PubMed ID: 9838826
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of purified endogenous inhibitor of the Na+/Ca2+ exchanger on ouabain-induced arrhythmias in the atria and ventricle strips of guinea pig.
    Shpak B; Gofman Y; Shpak C; Hiller R; Boyman L; Khananshvili D
    Eur J Pharmacol; 2006 Dec; 553(1-3):196-204. PubMed ID: 17078946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Determination of plasma levels of cardiovascular anti-arrhythmia drugs. Technical aspects and clinical prospectives].
    Paoletti V; Galeotta G; Faletra E; Cavina G; Mammarella A
    Clin Ter; 1987 Mar; 120(6):529-37. PubMed ID: 2954745
    [No Abstract]   [Full Text] [Related]  

  • 38. How do pharmacokinetics relate to pharmacodynamics of antiarrhythmic drugs?
    Shanks RG
    Eur Heart J; 1988 Feb; 9 Suppl B():51-6. PubMed ID: 3286268
    [No Abstract]   [Full Text] [Related]  

  • 39. [Significance of magnesium in cardiac arrhythmias].
    Stühlinger HG; Kiss K; Smetana R
    Wien Med Wochenschr; 2000; 150(15-16):330-4. PubMed ID: 11105328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lidocaine as an anti-arrhythmia agent. The pharmacological, experimental and clinical background for its use].
    Flensted-Jensen E
    Ugeskr Laeger; 1969 Mar; 131(12):500-4. PubMed ID: 5793604
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.